Abstract
We present an agent based simulation model configured for exploring the dynamics of disease spread in the context of agents that group together through homophily, the principle of “like attracts like”. To study the properties of this model, we introduce two novel social network inter-connectivity measures, “clumpiness” and “hoprank,” that are the same basic concept defined at global and local levels, respectively. The measures may be computed from samples of readily available demographic data, and are useful for measuring probabilistic packet transmission through social networks. In three studies we apply clumpiness to measure the effects, on COVID-19 transmission, caused by social networks of both homophilic physical proximity and homophilic information replication. The particular characteristic we are interested in about disease transmission is herd immunity, the percentage of a population that has to be immune in order to prevent infection from spreading to those who are not. Two studies demonstrate innovations measuring herd immunity levels and predicting future outbreak locations, procedures relevant to epidemiological control policy. In the first study, we look at how homophilic physical proximity networks form natural bubbles that act as frictive surfaces that affect the speed of transmission of packets and influence herd immunity levels. In the second study, we test clumpiness in homophilic proximity social networks as a predictor of future infection outbreaks at the level of individual schools, restaurants, and workplaces. Our third study demonstrates that protective social bubbles form naturally from homophilic information replication networks, and enhance the natural bubbles that come from the homophilic physical proximity networks. Accurate description of this information environment lays the foundation for epidemiological messaging policy formation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
All authors except for James Boyd were paid for their work by their employer SingularityNET Foundation. No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No human subjects were involved in this research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
ben{at}singularitynet.io, cassio{at}singularitynet.io, deborah{at}singularitynet.io, matt{at}singularitynet.io, michael{at}singularitynet.io, andre{at}singularitynet.io, ramon{at}singularitynet.io, boydj680{at}newschool.edu
Data Availability
This was a simulation. Parameters were set based upon data published in openly available sources. All other data was internally generated.
